全文获取类型
收费全文 | 15817篇 |
免费 | 748篇 |
国内免费 | 375篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 146篇 |
妇产科学 | 299篇 |
基础医学 | 1979篇 |
口腔科学 | 247篇 |
临床医学 | 1042篇 |
内科学 | 2094篇 |
皮肤病学 | 217篇 |
神经病学 | 858篇 |
特种医学 | 265篇 |
外国民族医学 | 6篇 |
外科学 | 761篇 |
综合类 | 2390篇 |
现状与发展 | 1篇 |
预防医学 | 760篇 |
眼科学 | 225篇 |
药学 | 3501篇 |
6篇 | |
中国医学 | 1330篇 |
肿瘤学 | 778篇 |
出版年
2023年 | 208篇 |
2022年 | 323篇 |
2021年 | 571篇 |
2020年 | 642篇 |
2019年 | 471篇 |
2018年 | 398篇 |
2017年 | 629篇 |
2016年 | 648篇 |
2015年 | 579篇 |
2014年 | 1401篇 |
2013年 | 2140篇 |
2012年 | 1782篇 |
2011年 | 1578篇 |
2010年 | 1157篇 |
2009年 | 942篇 |
2008年 | 784篇 |
2007年 | 405篇 |
2006年 | 360篇 |
2005年 | 332篇 |
2004年 | 264篇 |
2003年 | 182篇 |
2002年 | 132篇 |
2001年 | 55篇 |
2000年 | 37篇 |
1999年 | 26篇 |
1998年 | 47篇 |
1997年 | 39篇 |
1996年 | 36篇 |
1995年 | 28篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 9篇 |
1990年 | 17篇 |
1989年 | 11篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 64篇 |
1984年 | 77篇 |
1983年 | 87篇 |
1982年 | 85篇 |
1981年 | 55篇 |
1980年 | 58篇 |
1979年 | 42篇 |
1978年 | 36篇 |
1977年 | 28篇 |
1976年 | 23篇 |
1975年 | 24篇 |
1974年 | 20篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 302 毫秒
991.
目的 探讨核转录因子-κB(NF-κB)及肿瘤坏死因子-α(TNF-α)在大鼠肺血管内巨噬细胞(PIM)内的表达及吡咯醛二硫氨基甲酸(PDTC)对其表达的影响.方法 SD大鼠随机分4组:对照组、PDTC对照组、CCI4组、CCI4+PDTC组.取动脉血作血气分析,静脉血测内毒素和肝功能.取肠系膜淋巴结作细菌培养.应用免疫组化方法 观察PIM的粘附、聚集情况,以及TNF-α和NF-κB的蛋白表达和定位.非放射性凝胶电泳阻滞实验(EMSA)检测NF-κB活性,SYBR Green I实时定量PCR方法 检测肺组织中TNF-α的mRNA表达.结果 CCl4组发展成肝肺综合征(HPS)模型,表现为PaO2、PaCO2降低和肺泡一动脉血氧分压(A-aDO2)升高,肝功能异常,内毒素血症.CCl4组肠系膜淋巴结培养阳性率为62.5%(5/8),与CCl4+PDTC组的66.7%(6/9)比较差异无统计学意义(P>0.05).CCl4组超过10个巨噬细胞的血管为60.8%(292/480),而CCl4+PDTC组仅为19.6%(106/540),两组比较差异有统计学意义(P<0.01).对照组和PDTC对照组中肺血管内无巨噬细胞聚集.免疫组化染色NF-κB和TNF-α蛋白均在CCl4组的PIM中表达.CCl4组的NF-κB活性和TNF-α的mRNA表达明显高于对照组、PDTC对照组和CCl4+PDTC组(均P<0.05).结论 NF-κB诱导PIM内TNF-α表达在HPS中发挥重要作用,PDTC通过抑制PIM中NF-κB的活性,降低PIM活性以及其中TNF-α表达,从而改善HPS. 相似文献
992.
993.
Hongzhong Wu Xin Liang Yishi Fang Xiaoran Qin Yuanxing Zhang Jianwen Liu 《Biomedicine & Pharmacotherapy》2008
Resveratrol has been shown recently to exhibit antimetastatic effect on various human solid tumors. However, the possible molecular mechanism for its antimetastatic action needs to be elucidated. In this study, we investigated the effect of resveratrol on metastasis potential of colon carcinoma cells under normoxia and hypoxia in vitro. These results showed that, resveratrol can restrict the migration, adhesion, invasion and MMP-9 and MMP-2 secretion in Lovo cells cultured under normoxia and hypoxia. Hypoxia and iron chelator 2,2′-dipyridyl treatment can stimulate the invasion and migration enhancement of Lovo cells, while resveratrol exhibited substantial resistance on the metastasis potential stimulation by inhibiting the mRNA expression of VEGF and MMP-9 in colon carcinoma cells under normoxia and hypoxia, reducing HIF-1α protein expression under hypoxia. Also, iron chelator 2,2′-dipyridyl treatment showed approximately the same effect on metastasis potential as Lovo cells cultured under hypoxia. These data demonstrated that, the antimetastatic effect of resveratrol under hypoxia were associated with the restriction of HIF-1α protein expression and stabilization, which could be a promising drug target for resveratrol in the development of an effective chemopreventive and anticancer therapy in human tumors. 相似文献
994.
Wen-Yi Tseng Yeong-Jian Jan Wu Tai-Yun Yang Nien-Yi Chiang Wen-Pin Tsai Siamon Gordon Gin-Wen Chang Chang-Fu Kuo Shue-Fen Luo Hsi-Hsien Lin 《Journal of microbiology, immunology, and infection》2018,51(4):485-491
Background
GPR56/ADGRG1 is a member of the adhesion-class G protein-coupled receptor (aGPCR) family important in brain development, oncogenesis and tumor metastasis. Like other aGPCRs, GPR56 is cleaved at the GPCR proteolysis site (GPS) motif into an N-terminal fragment (NTF) and a C-terminal fragment (CTF). Existence of soluble GPR56 (sGPR56) has been shown in vitro, however the underlying mechanism and its pathophysiologic role remains undetermined.Objective
To assess the presence of sGPR56 in human serum using ELISA assay and compare the serum sGPR56 levels among patients of various chronic inflammatory diseases and healthy subjects.Patients and methods
In this study, serum samples from patients with systemic lupus erythematosus (SLE) (n = 57), rheumatoid arthritis (RA) (n = 95), Sjögren's syndrome (SS) (n = 29), ankylosing spondylitis (AS) (n = 51), and normal controls (n = 81) were analyzed using sGPR56-specific ELISA.Result
We show that serum sGPR56 levels are increased in patients of RA, but not in those with SLE, SS and AS. Intriguingly, serum sGPR56 levels in RA patients correlated with positive rheumatoid factor, a marker of bone erosion and poor outcome. In addition, an elevated sGPR56 level is also noted in RA patients with higher tumor necrosis factor level.Conclusion
we conclude that sGPR56 is present in vivo and sGPR56 level is elevated in certain chronic inflammatory diseases such as RA. Hence, sGPR56 might be considered a potential biomarker for RA disease progression. 相似文献995.
Desirée Schubert Marie-Christine Klein Sarah Hassdenteufel Andrés Caballero-Oteyza Linlin Yang Michele Proietti Alla Bulashevska Janine Kemming Johannes Kühn Sandra Winzer Stephan Rusch Manfred Fliegauf Alejandro A. Schäffer Stefan Pfeffer Roger Geiger Adolfo Cavalié Hongzhi Cao Fang Yang Bodo Grimbacher 《The Journal of allergy and clinical immunology》2018,141(4):1427-1438
996.
Benjamin F. Sallis Lena Erkert Sherezade Moñino-Romero Utkucan Acar Rina Wu Liza Konnikova Willem S. Lexmond Matthew J. Hamilton W. Augustine Dunn Zsolt Szepfalusi Jon A. Vanderhoof Scott B. Snapper Jerrold R. Turner Jeffrey D. Goldsmith Lisa A. Spencer Samuel Nurko Edda Fiebiger 《The Journal of allergy and clinical immunology》2018,141(4):1354-1364.e9
997.
998.
999.
Franziska Sotzny Julià Blanco Enrica Capelli Jesús Castro-Marrero Sophie Steiner Modra Murovska Carmen Scheibenbogen 《Autoimmunity reviews》2018,17(6):601-609
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a frequent and severe chronic disease drastically impairing life quality. The underlying pathomechanism is incompletely understood yet but there is convincing evidence that in at least a subset of patients ME/CFS has an autoimmune etiology. In this review, we will discuss current autoimmune aspects for ME/CFS. Immune dysregulation in ME/CFS has been frequently described including changes in cytokine profiles and immunoglobulin levels, T- and B-cell phenotype and a decrease of natural killer cell cytotoxicity. Moreover, autoantibodies against various antigens including neurotransmitter receptors have been recently identified in ME/CFS individuals by several groups. Consistently, clinical trials from Norway have shown that B-cell depletion with rituximab results in clinical benefits in about half of ME/CFS patients. Furthermore, recent studies have provided evidence for severe metabolic disturbances presumably mediated by serum autoantibodies in ME/CFS. Therefore, further efforts are required to delineate the role of autoantibodies in the onset and pathomechanisms of ME/CFS in order to better understand and properly treat this disease. 相似文献
1000.
α_1-抗胰蛋白酶活性测定方法及其影响因素的研究 总被引:1,自引:2,他引:1
目的研究用发色底物法测定α1-AT生物活性时,以正常人混合血浆为参考标准的血浆稀释度范围和测定的影响因素。方法采用酶标仪测定抗胰蛋白酶与过量的胰蛋白酶反应后,剩余的胰蛋白酶与BAPNA发色反应的OD值(405nm),观察时间和温度对反应的影响,优化正常人混合血浆(30人份)稀释度范围,建立并验证血浆标准曲线,同时观察几种物质对测定的影响。结果通过优化实验,血浆的稀释倍数在1/50~1/100之间有良好的线性;PEG4000、蔗糖、Tween80/TNBP(S/D)、辛酸钠等对活性测定无明显影响,而枸橼酸钠浓度>0.125mol/L,α1-AT生物活性测定结果偏高约20%。结论以正常人混合血浆为参考标准品,用酶标仪测定α1-AT的生物活性,快速、准确,方法稳定可靠,α1-AT制备过程中常用的几种物质,除枸橼酸钠外,对其活性测定均无影响。 相似文献